Table 1. Clinical characteristics of the lung cancer patients.

Patients number	Age (years)	Gender	Histology	Staging	Smoking status	Pack-years	Medication
1	57	Male	Adenocarcinoma	2B	Never smoker	–	None
2	41	Female	Adenocarcinoma	4	Never smoker	–	None
3	67	Male	Squamous cell carcinoma	4	Ex-smoker	168	MDI
4	77	Male	Squamous cell carcinoma	3A	Ex-smoker	86	OHA, anti-HPT
5	56	Male	Squamous cell carcinoma	3B	Current smoker	54	None
6	65	Male	Adenocarcinoma	4	Ex-smoker	27	Aspirin, statin, anti-HPT
7	55	Male	Adenocarcinoma	4	Never smoker	–	None
8	54	Female	Adenocarcinoma	4	Never smoker	–	OHA
9	42	Male	Adenosquamous carcinoma	4	Current smoker	8	None
10	76	Female	Adenocarcinoma	4	Never smoker	–	None
11	63	Female	Adenocarcinoma	2B	Ex-smoker	56	None
12	78	Male	Adenocarcinoma	3B	Ex-smoker	121	MDI

MDI, metered dose inhaler; OHA, oral hypoglycemic anti-diabetic medication; anti-HPT, antihypertensive drug.